NATHBIOGEN · NSE

Nath Bio-Genes (India) Limited

₹148.02

-0.24% (-₹0.36)

Prev. close

₹148.38

Volume

97,539

Delivery %

97.3%

As of

23 Sept 2026

Price history

₹148.02-₹21 (-12.42%) · 3M
15 Jun 202623 Sept 2026
₹172.01₹146.0515 Jun08 Jul06 Aug31 Aug23 Sept
Daily closes · updates after each session

No analyst calls on this stock in the last 90 days yet.

Explore by date range →

Analyst opinions

No analyst calls on Nath Bio-Genes (India) Limited in the last 90 days.

Fundamentals

About Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; fruit seeds, which includes Rustam +, Rustam, Mukhiya, and Ranjit; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; and seeds for vegetables comprising cabbage, French beans, chili, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, coriander, sweet pepper, green peas, pumpkin, and tinda. It also provides plant protection products under the Win-chi-Win, WINPro WinGoli, and WINall brands; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX brand names. The company was founded in 1979 and is based in Mumbai, India.

Details

Sector

Basic Materials

Industry

Agricultural Inputs

CEO

Mr. Satish Kagliwal

Headquarters

Mumbai

Employees

452

Key stats

Market cap

₹281.69 Cr

P/E ratio (TTM)

6.2

Dividend yield

1.35%

EPS (TTM)

₹24.01

Beta (1Y · daily vs NIFTY 50)

0.89

Beta (5Y · monthly vs NIFTY 50)

1.77

Shares float

60.50 L

EPS · quarter ended Jun 2026

₹16.98

Financial Performance

01 · Financials

-250 Cr0 Cr250 Cr500 Cr-20%0%20%40%FY21FY22FY23FY24FY25FY26
RevenueNet incomeEBITDARevenue growth YoY

FY21 growth needs FY20 filings, which the data source doesn't provide.

02 · Earnings Per Share (EPS)

-40-2002040FY21FY22FY23FY24FY25FY26

03 · Dividend Profile

011220%1%2%3%18 Aug 2123 Jun 2204 Jul 2309 Aug 2414 Aug 2511 Sept 26
Dividend (₹/share)Annualised yieldAnnual dividend growth (FY)

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based

-25%0%25%50%FY21FY22FY23FY24FY25FY26
SalesFixed assetsReceivables (trade + unbilled)Inventory

05 · Capital Structure & Asset Utilization

0 Cr500 Cr1000 Cr1500 Cr0.2×0.4×0.6×FY21FY22FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

0 Cr500 Cr1000 Cr1500 CrFY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

-100 Cr0 Cr100 Cr200 CrFY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹307.56 Cr₹278.36 Cr₹301.36 Cr₹332.62 Cr₹364.91 Cr₹445.10 Cr
EBITDA₹68.39 Cr₹-49.69 Cr₹51.76 Cr₹56.72 Cr₹54.30 Cr₹66.26 Cr
₹55.66 Cr₹-67.34 Cr₹35.01 Cr₹39.62 Cr₹38.60 Cr₹41.63 Cr
Diluted EPS₹29.29₹-35.43₹18.42₹20.85₹20.14₹21.91

EBITDA for Mar 2022 could not be independently verified against the company's own annual report: this page shows ₹-49.69 Cr while the annual report gives ₹39.09 Cr (178.7% apart). That disagreement leaves the whole cross-check inconclusive, so EBITDA for Mar 2020 (the annual report alone gives ₹56.51 Cr) is left blank here too, rather than shown from only one of the two sources.

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹789.51 Cr₹739.49 Cr₹792.80 Cr₹880.23 Cr₹1,026.21 Cr₹1,097.42 Cr
₹92.96 Cr₹105.21 Cr₹110.35 Cr₹122.50 Cr₹138.50 Cr
Stockholders' equity₹613.28 Cr₹541.93 Cr₹573.17 Cr₹609.92 Cr₹644.39 Cr₹680.46 Cr

Current assets, Receivables (trade + unbilled), Trade receivables, Unbilled receivables (contract assets), Non-current assets, Fixed assets, CWIP, Others, Total debt, Long-term debt, Current (short-term) debt have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹1.12 Cr₹17.05 Cr₹38.37 Cr₹74.59 Cr₹17.58 Cr₹-12.57 Cr
Investing cash flow₹-10.28 Cr₹-19.87 Cr₹-2.88 Cr₹-27.40 Cr₹-3.96 Cr₹3.46 Cr
₹16.40 Cr₹-22.23 Cr₹-1.67 Cr₹-7.78 Cr₹-2.13 Cr₹-3.81 Cr
Capital expenditure₹-11.60 Cr₹-1.13 Cr₹-2.55 Cr₹-26.78 Cr₹-7.92 Cr₹-3.13 Cr
End cash position₹29.22 Cr₹4.18 Cr₹38.00 Cr₹77.41 Cr₹88.90 Cr₹75.97 Cr

Annual only — the data source has no quarterly cash-flow-statement coverage.

11 · Shareholding Pattern

NSE, quarterly

Line itemJun 21Dec 21(3Q)Mar 22Jun 22Sep 22Jun 26(16Q)
Promoter41.03%41.05%41.07%45.60%
Public58.97%58.95%58.93%54.40%
Employee trusts0.00%0.00%0.00%0.00%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

12 · Peer Comparison

Basic Materials

Company
UltraTech Cement Limited₹3.24 L Cr₹11,15538.04.2210.7%0.31+16.6%-10.0%
JSW Steel Limited₹3.10 L Cr₹1,26712.53.0922.3%1.19+9.3%+13.4%
Hindustan Zinc Limited₹2.50 L Cr₹595.4514.611.0361.1%0.39+18.6%+29.0%
Asian Paints Limited₹2.34 L Cr₹2,448.549.010.9520.2%0.18+5.1%-1.4%
Tata Steel Limited₹2.31 L Cr₹190.8220.92.2610.6%0.90+6.2%+10.1%
Hindalco Industries Limited₹2.16 L Cr₹1,003.813.21.589.8%0.73+15.0%+34.6%
Grasim Industries Limited₹2.12 L Cr₹3,188.537.32.054.8%2.20+18.2%+13.3%
Solar Industries India Limited₹1.80 L Cr₹19,73090.628.6726.7%0.29+30.6%+38.8%
Vedanta Aluminium Metal Limited₹1.63 L Cr₹413.0542.4
Pidilite Industries Limited₹1.60 L Cr₹1,588.160.614.7922.6%0.04+11.1%+6.6%
JINDAL STEEL LIMITED₹1.16 L Cr₹1,175.342.42.286.6%0.44+5.5%+10.6%
Nath Bio-Genes (India) Limited₹282.37 Cr₹148.026.20.416.1%0.20+22.0%

Ranked by market cap within Basic Materials, same metrics as the Fundamentals screener. Click a column to sort.

Documents

Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.

No stock news captured yet.